Respira appoints new CEO to drive inhalable therapeutics
Drug Discovery World
AUGUST 19, 2022
Clinical-stage company Respira Technologies has appointed a new Chief Executive Officer (CEO) to the company. . Brian Quigley will take over as CEO after working as Respira’s Chief Operating Officer (COO) for the past two years. . Quigley previously worked at Altria Group for 16 years where he spent seven years as President & CEO at Altria’s Smokeless and Innovative Products/Vapor Businesses. .
Let's personalize your content